Adaptyv Biosystems, with a valuation of $12 million, is raising funds on Wefunder. The company uses synthetic biology and nanofluidics for protein engineering. The business and its technology interface with standard antibody discovery pipelines and massively increase the number of antibodies that can be screened. Adaptyv Biosystems is working on building the best platform to engineer proteins based on high-throughput nanofluidics and train machine-learning models to predict new protein designs. Julian Englert, Moustafa Homani, Amir Shahein, and Daniel Nakhaee Zadeh Gutierrez founded Adaptyv Biosystems in July 2021. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $107,000. The campaign proceeds will be used for R&D expenses.